The Prevalence of Tardive Dyskinesia in Neuroleptic-Treated Diabetics: A Controlled Study

Linda Ganzini, Ronald T. Heintz, William F. Hoffman, Daniel E. Casey

Research output: Contribution to journalArticle

91 Scopus citations

Abstract

In a controlled study, we compared the prevalence of tardive dyskinesia in 38 neuroleptic-treated diabetics with the prevalence of tardive dyskinesia in a group of 38 nondiabetic neuroleptic-treated controls, matched for age, sex, psychiatric diagnosis, and dose and duration of neuroleptic treatment. Members of each group were evaluated for movement disorders by a rater who used standard rating scales and was “blind” to all diagnoses and treatments. Neuroleptic-treated diabetics had a significantly higher prevalence and severity of tardive dyskinesia. There were no differences between groups on other possible risk factors for tardive dyskinesia, including parkinsonism, anticholinergic drug treatment, or cognitive function. These data suggest that diabetes mellitus should be examined further as a risk factor for tardive dyskinesia.

Original languageEnglish (US)
Pages (from-to)259-263
Number of pages5
JournalArchives of General Psychiatry
Volume48
Issue number3
DOIs
StatePublished - Mar 1991

ASJC Scopus subject areas

  • Arts and Humanities (miscellaneous)
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'The Prevalence of Tardive Dyskinesia in Neuroleptic-Treated Diabetics: A Controlled Study'. Together they form a unique fingerprint.

  • Cite this